Finding 1173937 (2023-005)

Material Weakness Repeat Finding
Requirement
L
Questioned Costs
-
Year
2023
Accepted
2026-02-17
Audit: 387535
Organization: National Indian Health Board (DC)
Auditor: SIKICH CPA LLC

AI Summary

  • Core Issue: Reports were submitted late, incomplete, and contained discrepancies, indicating a material weakness in compliance.
  • Impacted Requirements: Compliance with Uniform Guidance 2 CFR 200 Subpart D for timely and accurate reporting is not being met.
  • Recommended Follow-Up: Grant personnel should track report deadlines, management must review submissions, and all documentation should be easily accessible to ensure compliance.

Finding Text

Late reports, incomplete reports and variances from accounting records 93.011 National Organizations for State and Local Officials 93.318 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security 93.341 Analyses, Research and Studies to Address the Impact of CMS Programs on American Indian/Alaska Native (AI/AN) Beneficiaries and the Health Care System Serving these Beneficiaries 93.421 Strengthening Public Health Systems and Services Criteria: Per Uniform Guidance 2 CFR 200 Subpart D, Performance and Financial Monitoring and Reporting, reports should be submitted within the required timeframe per the grant agreement and should tie out to the financial records. Documentation should also be kept for all financial and programmatic reports submitted for all federal awards. Condition: The Organization did not submit reports timely for five out of ten reports tested (50%). We also noted one report that was incomplete. Additionally, we identified a report in which there was a significant discrepancy between the figures in the accounting records and those presented in the report. We consider this condition to be a material weakness to the Reporting compliance requirement and is a repeat finding shown in Section IV of this report as prior year finding 2022 005. Statistical sampling was not used in making sample selections. Questioned costs: None Effect: As a result, certain reports were filed late and one was incomplete, which may affect the accuracy of the reports and require additional oversight in the future. Cause: The late reports and variances are due to ineffective controls over reporting resulting from employee turnover, resulting in delays and missing documentation to support the variances. Recommendation: Auditors recommend that grant personnel track all deadlines for submission of reports and that management be aware of these deadlines and track and review all submissions to ensure timely and accurate fillings. If there are delays, the Organization should request and document permission to submit late. The Organization should also maintain all federal award reporting documentation in a location where authorized personnel have access in order to ensure that it can always be located. It is critical to maintain complete and accurate documentation to ensure compliance with Uniform Guidance requirements. Views of Responsible Officials and Planned Corrective Actions: Management agrees with this Single Audit Finding and response is included in the Corrective Action Plan.

Corrective Action Plan

Management has strengthed both financial reporting controls and ovesight procedures. Sage Intacct ERP system was implemented in 2024 to enhance grant level reporting accurary and reconciliation capabilities. In addition, a comprehensive reporting tracker that monitors deadlines were implemented to improve timeliness of submission of financial and programmatic reports. All federal financial reports are now reconciled with the general ledger and verifying that grant deliverables are met in accordance with the Uniform Guidance. These measures are designed to prevent future late or missing reports and to ensure that funds are properly expended and documented. In addition, all federal financial reports are reconciled to the general ledger prior to submission. A grant reporting reconciliation form is completed and signed by both the Grants Director and Finance staff verifying agreement between accounting records and submitted reports. Reports may not be submitted until the reconciliation documentation is completed and retained.

Categories

Reporting Subrecipient Monitoring Material Weakness

Other Findings in this Audit

  • 1173851 2023-005
    Material Weakness Repeat
  • 1173852 2023-006
    Material Weakness Repeat
  • 1173853 2023-007
    Material Weakness Repeat
  • 1173854 2023-008
    Material Weakness Repeat
  • 1173855 2023-004
    Material Weakness Repeat
  • 1173856 2023-005
    Material Weakness Repeat
  • 1173857 2023-006
    Material Weakness Repeat
  • 1173858 2023-007
    Material Weakness Repeat
  • 1173859 2023-008
    Material Weakness Repeat
  • 1173860 2023-004
    Material Weakness Repeat
  • 1173861 2023-005
    Material Weakness Repeat
  • 1173862 2023-006
    Material Weakness Repeat
  • 1173863 2023-007
    Material Weakness Repeat
  • 1173864 2023-008
    Material Weakness Repeat
  • 1173865 2023-004
    Material Weakness Repeat
  • 1173866 2023-005
    Material Weakness Repeat
  • 1173867 2023-006
    Material Weakness Repeat
  • 1173868 2023-007
    Material Weakness Repeat
  • 1173869 2023-008
    Material Weakness Repeat
  • 1173870 2023-004
    Material Weakness Repeat
  • 1173871 2023-005
    Material Weakness Repeat
  • 1173872 2023-006
    Material Weakness Repeat
  • 1173873 2023-007
    Material Weakness Repeat
  • 1173874 2023-008
    Material Weakness Repeat
  • 1173875 2023-004
    Material Weakness Repeat
  • 1173876 2023-005
    Material Weakness Repeat
  • 1173877 2023-006
    Material Weakness Repeat
  • 1173878 2023-007
    Material Weakness Repeat
  • 1173879 2023-008
    Material Weakness Repeat
  • 1173880 2023-004
    Material Weakness Repeat
  • 1173881 2023-005
    Material Weakness Repeat
  • 1173882 2023-006
    Material Weakness Repeat
  • 1173883 2023-007
    Material Weakness Repeat
  • 1173884 2023-008
    Material Weakness Repeat
  • 1173885 2023-004
    Material Weakness Repeat
  • 1173886 2023-005
    Material Weakness Repeat
  • 1173887 2023-006
    Material Weakness Repeat
  • 1173888 2023-007
    Material Weakness Repeat
  • 1173889 2023-008
    Material Weakness Repeat
  • 1173890 2023-004
    Material Weakness Repeat
  • 1173891 2023-005
    Material Weakness Repeat
  • 1173892 2023-006
    Material Weakness Repeat
  • 1173893 2023-007
    Material Weakness Repeat
  • 1173894 2023-008
    Material Weakness Repeat
  • 1173895 2023-004
    Material Weakness Repeat
  • 1173896 2023-005
    Material Weakness Repeat
  • 1173897 2023-006
    Material Weakness Repeat
  • 1173898 2023-007
    Material Weakness Repeat
  • 1173899 2023-008
    Material Weakness Repeat
  • 1173900 2023-004
    Material Weakness Repeat
  • 1173901 2023-005
    Material Weakness Repeat
  • 1173902 2023-006
    Material Weakness Repeat
  • 1173903 2023-007
    Material Weakness Repeat
  • 1173904 2023-008
    Material Weakness Repeat
  • 1173905 2023-004
    Material Weakness Repeat
  • 1173906 2023-005
    Material Weakness Repeat
  • 1173907 2023-006
    Material Weakness Repeat
  • 1173908 2023-007
    Material Weakness Repeat
  • 1173909 2023-008
    Material Weakness Repeat
  • 1173910 2023-004
    Material Weakness Repeat
  • 1173911 2023-005
    Material Weakness Repeat
  • 1173912 2023-006
    Material Weakness Repeat
  • 1173913 2023-007
    Material Weakness Repeat
  • 1173914 2023-008
    Material Weakness Repeat
  • 1173915 2023-004
    Material Weakness Repeat
  • 1173916 2023-005
    Material Weakness Repeat
  • 1173917 2023-006
    Material Weakness Repeat
  • 1173918 2023-007
    Material Weakness Repeat
  • 1173919 2023-008
    Material Weakness Repeat
  • 1173920 2023-005
    Material Weakness Repeat
  • 1173921 2023-006
    Material Weakness Repeat
  • 1173922 2023-008
    Material Weakness Repeat
  • 1173923 2023-005
    Material Weakness Repeat
  • 1173924 2023-006
    Material Weakness Repeat
  • 1173925 2023-008
    Material Weakness Repeat
  • 1173926 2023-004
    Material Weakness Repeat
  • 1173927 2023-005
    Material Weakness Repeat
  • 1173928 2023-006
    Material Weakness Repeat
  • 1173929 2023-007
    Material Weakness Repeat
  • 1173930 2023-008
    Material Weakness Repeat
  • 1173931 2023-004
    Material Weakness Repeat
  • 1173932 2023-005
    Material Weakness Repeat
  • 1173933 2023-006
    Material Weakness Repeat
  • 1173934 2023-007
    Material Weakness Repeat
  • 1173935 2023-008
    Material Weakness Repeat
  • 1173936 2023-004
    Material Weakness Repeat
  • 1173938 2023-006
    Material Weakness Repeat
  • 1173939 2023-007
    Material Weakness Repeat
  • 1173940 2023-008
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.341 ANALYSES, RESEARCH AND STUDIES TO ADDRESS THE IMPACT OF CMS’ PROGRAMS ON AMERICAN INDIAN/ALASKA NATIVE (AI/AN) BENEFICIARIES AND THE HEALTH CARE SYSTEM SERVING THESE BENEFICIARIES $804,408
93.011 NATIONAL ORGANIZATIONS FOR STATE AND LOCAL OFFICIALS $498,838
66.309 SURVEYS, STUDIES, INVESTIGATIONS, TRAINING AND SPECIAL PURPOSE ACTIVITIES RELATING TO ENVIRONMENTAL JUSTICE $467,089
93.421 STRENGTHENING PUBLIC HEALTH SYSTEMS AND SERVICES THROUGH NATIONAL PARTNERSHIPS TO IMPROVE AND PROTECT THE NATION’S HEALTH $101,462
93.318 PROTECTING AND IMPROVING HEALTH GLOBALLY: BUILDING AND STRENGTHENING PUBLIC HEALTH IMPACT, SYSTEMS, CAPACITY AND SECURITY $100,994
93.933 DEMONSTRATION PROJECTS FOR INDIAN HEALTH $83,041